What can be done about acute renal failure?

Minerva Anestesiologica

Volumn 70, Issue 4, 2004, Pages 181-188

  Kellum, J A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bone morphogenetic proteins; Dialysis; Diuretics; Erythropoietin; Kidney failure, acute, therapy; Recovery; Renal blood flow

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE; AMPHOTERICIN; AMPHOTERICIN B LIPID COMPLEX; ANARITIDE; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; DILTIAZEM; DIURETIC AGENT; DOPAMINE; DOPEXAMINE; ERYTHROPOIETIN; FENOLDOPAM; FUROSEMIDE; NIFEDIPINE; OSTEOGENIC PROTEIN 1; PENTOXIFYLLINE; PLACEBO; ROLIPRAM; SCATTER FACTOR; SOMATOMEDIN; THEOPHYLLINE; URODILATIN; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ARTICLE; CELL REGENERATION; CLINICAL PRACTICE; CONVALESCENCE; CRITICAL ILLNESS; DEHYDRATION; DETERIORATION; DISEASE COURSE; FLUID THERAPY; HEMODIALYSIS; HOSPITAL PATIENT; HUMAN; HYPOTENSION; INCIDENCE; KIDNEY FUNCTION; OUTCOMES RESEARCH; PERITONEAL DIALYSIS; RISK ASSESSMENT; TREATMENT FAILURE;

HUMANS; INTENSIVE CARE; KIDNEY FAILURE, ACUTE; RENAL DIALYSIS;

EID: 3142782983     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-8.
2. Bellomo R, Ronco C. The changing pattern of severe acute renal failure. Nephrology 1991;2:602-10.
3. Kellum JA, Angus DC. Patients are dying of acute renal failure. Crit Care Med 2002;30:2156-7.
4. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002;30:2051-8.
5. Hoste EA, Lameire N, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Neprhol 2003;14:1022-30.
6. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. JAMA 1998;104:343-8.
7. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: A cohort analysis. JAMA 1996;275:1489-94.
8. Hoste EA, Clermont G, Kersten A, et al. Clinical evaluation of the new RIFLE criteria for acute renal failure. Crit Care 2004;8(Suppl 1):P162.
9. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20.
10. Better OS, Rubinstein I. Management of shock and acute renal failure in casualties suffering from the crush syndrome. Renal Failure 1997;19:647-53.
11. Mueller C, Buerkle G, Buettner HJ. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimes in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:329-36.
12. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998;31:674-80.
13. Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998;26:1383-96.
14. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high - and low-osmolality iodinated contrast media. Radiology 1993;188:171-8.
15. Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003;362: 598-603.
16. Kellum JA, A drug to prevent renal failure? Lancet 2003;362:589-90.
17. Kellum JA. The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence. Crit Care 1997;1:53-9.
18. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000;11:97-104.
19. Mehta RL, Pascual MT, Soroko S, Chertow GM. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002;288:2547-53.
20. Ip-Yam PC, Murphy S, Baines M. Renal function and proteinuria after cardiopulmonary bypass: the effects of temperature and mannitol. Anesth Analg 1994;78; 842-7.
21. Homsi E, Barreiro MF, Orlando JM, Higa EM. Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail 1997;19:283-8.
22. Beall AC, Holman MR, Morris GC. Mannitol-induced osmotic diuresis during vascular surgery. Arch Surg 1963;86:34-42.
23. Gubern JM, Sancho JJ, Simo J. A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice. Surgery 1988;103: 39-44.
24. Kellum JA, Decker JM. The use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001;29:1526-31.
25. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med 2002;28:877-83.
26. Australian and New Zealand Intensive Care Society Clinical Trials Group. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Dopamine in Critically Ill Patients with Early Renal Dysfunction. Lancet 2000;356:2139-43.
27. Halpenny M, Lakshmi S, O'Donnell A, O'Callaghan-Enright S, Shorten GD. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 2001;56;953-60.
28. Halpenny M, Rushe C, Breen P, Cunningham AJ, Boucher-Hayes D, Shorten GD. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 2002;19:32-9.
29. Tumlin JA, Wang A, Murray PT, Mathur VS. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am Heart J 2002;143:894-903.
30. Allaqaband S. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 2002;57:279-83.
31. Chu VL, Cheng GW. Fenoldopam in the prevention of contrast media-induced acute renal failure. Ann Pharmacother 2001;35:1278-82.
32. Mathur VS, Swan SK, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999;27:1832-7.
33. Subramanian S, Venkataraman R, Kellum JA. Influence of dialysis membranes on outcomes in acute renal failure: a meta-analysis. Kidney Int 2002;62:1819-23.
34. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P. et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
35. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305-10.
36. Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C; ADQI Workgroup. The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002;62:1855-63.
37. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002;28:29-37.
38. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med 1999;25:805-13.
39. Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-8.
40. Liu KD. Molecular mechanisms of recovery from acute renal failure. Crit Care Med 2003;31[Suppl]:S572-S581.
41. Vanholder RC, De Smet R, Waterloos MA, Van Landschoot N, Vogeleere P, Hoste E et al. Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 1995;47:510-7.
42. Venkataraman R, Kellum JA. Novel approaches to the treatment of acute renal failure. Expert Opin Investig Drugs 2003;12:1353-66.
43. Wang SN, Lapage J, Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Neprhol 2001;12:2392-9.
44. Westenfelder C. Unexpected renal actions of erythropoietin. Exp Nephrol 2002;10:294-8.
45. Liangos O, Pereira B, Jaber BL. Anemia in acute renal failure: role for erythropoiesis-stimulating proteins? Artif Organs 2003;27:786-91.